The CE stamp tells us that Medizone has absolutely no government obstacles to selling Asepticsure in Europe. That same CE stamp, in my humble pea brain, then tells me that it encompasses everything our EPA/FDA could represent. Five years ago, IMHO, an EPA approval and/or a CE stamp would have had this stock trading above a dollar per share before everyone reminded themselves that there was no infrastructure to support a marketing program. The only excuse the company has today to not sell Asepticsure is the fact that there is still no marketing program. Maybe the company was blindsided with this great news. Whatever the circumstances, Medizone needs marketing partners or a final sale of the company. It's now or never.
